Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
TORONTO, Oct. 3, 2013 /CNW/ - MediJean is taking bold steps in favour of building an industry-leading and new vision for what a medical marijuana company stands for and how it should operate. The company is putting research first, growing pharma-grade, quality-assured cannabis. MediJean will ensure that people who need medical marijuana receive the highest-quality medicine available on the market.
Earlier this week MediJean announced it had been approved by Health Canada to become one of the first companies in Canada to legally be allowed to grow medical marijuana for R&D purposes.
"We are going to focus on what's best for the people who need real medicine," said Anton Mattadeen, Chief Strategy Officer for MediJean. "Our R&D team will be drawing from more than 500 known strains of cannabis to develop the highest-quality medical marijuana available. This process, in combination with MediJean's 1,500 baseline quality assurance checks will ensure the patient who needs medical marijuana will receive a pharma-grade product that has gone through rigorous testing before it is distributed."
As more Canadians require medical marijuana supplied by a licensed producer, MediJean believes patients should look for a company that actively conducts research and development and meets stringent quality assurance protocols for their medicine. "It will be up to these people to hold companies to account, but any company looking to achieve credibility in this new industry should actively conduct R&D and ensure they are adhering to Good Manufacturing Practices as defined in the Food and Drug Act, as well as the guiding principles of Hazard Analysis Critical Control Point, (HACCP)" said Mattadeen.
MediJean says quality needs to be the most important aspect for people when they are looking for medical marijuana. They believe that many people are completely unaware of what they are putting into their body when they are using "street pot" as a substitute for medical cannabis. "Every medical marijuana user should be wary of mold, bugs, carcinogens and other harmful contaminants," said Mattadeen. "We have heard horror stories of window cleaner and other chemicals being sprayed on marijuana that is available on the street. Obtaining marijuana from these sources means there's just simply no way to know the makeup of what is being purchased." MediJean's interest is to develop the best solutions for everybody who requires this medicine. "We believe that people who require medical marijuana should have access to exactly what they need, at the highest quality levels possible," said Mattadeen. "This is why I am inviting anybody interested in learning more about MediJean's plans for moving the industry forward to visit http://medijean.com."
MediJean is leading the rebirth of medical marijuana through a laser focus on research, quality and patient experience by implementing best practices here and around the world. Doctors and Nurse Practitioners will understand and safely prescribe it within a clinical framework, patients will have access to clean and affordable medicine, and university research partners will help the company expand the frontiers of medical marijuana in the years ahead.
©2012 PR Newswire. All Rights Reserved.